Peanut allergy research reveals systemic gaps: How colonial food science obscures Indigenous plant medicine and corporate biotech capture
Original framing: “Pumpkin-derived enzyme weakens peanut proteins' binding to allergy antibodies in lab tests” — Phys.org
The figleaf gourd (*Cucurbita ficifolia*) is a staple of Andean and Mesoamerican agriculture, where it was domesticated alongside maize and potatoes over 7,000 years ago. Indigenous farmers in Peru and Mexico have long observed its digestive benefits, using it in *chicha* (fermented drinks) and *mote* (toasted grains) to ease stomach sensitivities—practices that align with modern allergy research but are excluded from Western lab narratives. The gourd’s enzymes were likely selected for over generations in traditional diets, yet the study credits ‘discovery’ to a Polish lab, erasing millennia of Indigenous plant breeding. This mirrors the broader pattern of biopiracy, where corporate and academic institutions patent Indigenous knowledge as ‘novel’ solutions.
This study exemplifies how colonial and neocolonial structures extract Indigenous plant knowledge—like the figleaf gourd’s enzymes—while obscuring its origins in Andean and Mesoamerican agriculture.
The rise of peanut allergies is not just a biological quirk but a symptom of disrupted diets caused by industrial agriculture and colonial trade, patterns ignored in the lab-focused narrative. Solutions must center Indigenous-led revitalization of traditional food systems, paired with decolonial patent reforms to prevent corporate capture of plant-based remedies. The trickster’s lens reveals the irony: while Western science celebrates ‘discovering’ what farmers have known for millennia, the same systems that suppress Indigenous voices will soon monetize these ‘breakthroughs,’ deepening health inequities. The path forward lies in equitable partnerships, where allergy research is co-designed with the communities who hold the answers—and where food is treated as medicine, not intellectual property.